Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
REPLIGEN CORP roe for the quarter ending 2026-06-30 was 1.97%, a change of 2.64% year-over-year.
REPLIGEN CORP roe for the quarter ending 2026-03-31 was 2.44%, a change of 3.60% year-over-year.
REPLIGEN CORP roe for the quarter ending 2025-12-31 was 2.32%, a change of 3.61% year-over-year.
REPLIGEN CORP roe for the quarter ending 2025-09-30 was 0.08%, a change of 0.48% year-over-year.
REPLIGEN CORP roe for fiscal 2025 was 2.32%, a change of 3.61% from fiscal 2024.
REPLIGEN CORP roe for fiscal 2024 was -1.29%, a 171.39% decline from fiscal 2023.
REPLIGEN CORP roe for fiscal 2023 was 1.81%, a 81.39% decline from fiscal 2022.
REPLIGEN CORP roe for fiscal 2022 was 9.73%, a 32.76% increase from fiscal 2021.